Literature DB >> 34300613

Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.

San-Ha Kim1, Jae-Young Han2, Min-Keun Song2, In-Sung Choi1, Hyeng-Kyu Park1.   

Abstract

Spinocerebellar ataxia (SCA) is a hereditary neurodegenerative disorder that presents as ataxia. Due to the decline in balance, patients with SCA often experience restricted mobility and a decreased quality of life. Thus, many studies have emphasized the importance of physiotherapies, including gait training, in SCA patients. However, few studies have examined the effectiveness of robotic gait training in SCA. Here, we report the therapeutic outcomes of exoskeleton-assisted gait training in a patient with SCA. A 23-year-old woman with SCA participated in a gait training program using a powered lower-limb robotic exoskeleton, ANGELLEGS. The 8-week training program consisted of standing training, weight-shifting exercises, and gait training. Several measures of general function, balance, gait, and cardiopulmonary function were applied before, after, and 4 weeks after the program. After the program, overall improvements were found on scales measuring balance and gait function, and these improvements remained at 4 weeks after the program. Cardiopulmonary function was also improved 4 weeks after the program. Robotic exoskeleton gait training can be a beneficial option for training balance, gait, and cardiopulmonary function in SCA.

Entities:  

Keywords:  exoskeleton; gait training; spinocerebellar ataxia

Year:  2021        PMID: 34300613     DOI: 10.3390/s21144874

Source DB:  PubMed          Journal:  Sensors (Basel)        ISSN: 1424-8220            Impact factor:   3.576


  2 in total

1.  The Effects of Over-Ground Robot-Assisted Gait Training for Children with Ataxic Cerebral Palsy: A Case Report.

Authors:  Myungeun Yoo; Jeong Hyeon Ahn; Eun Sook Park
Journal:  Sensors (Basel)       Date:  2021-11-26       Impact factor: 3.576

2.  Robot Assisted Gait Training in a Patient with Ataxia.

Authors:  Gianfranco Lamberti; Gianluca Sesenna; Martina Marina; Emanuela Ricci; Gianluca Ciardi
Journal:  Neurol Int       Date:  2022-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.